Sponsor Pipeline

Laboratoires Thea Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
6
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 3
1
Phase 2
3
Phase 1/2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06903741 New Preservative-free Combination of Trehalose, Sodium Hyaluronate and… Dry Eye Disease (DED) Recruiting
Phase 3
NCT06891443 Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10… Leber Congenital Amaurosis 10 Recruiting
Phase 2
NCT07522242 Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression Myopia Recruiting
NCT07169695 A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in… Moderate to Severe Vernal Keratoconjunctivitis Recruiting
NCT06627179 Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations… Retinitis Pigmentosa (RP) Active, Not Recruiting
Phase 1/2
NCT05389267 Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. Glaucoma Active, Not Recruiting
Not specified
NCT07206628 Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using… Adherence to Glaucoma Therapy Recruiting
NCT07234292 Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid… Eyelid; Wound Recruiting
Disease Areas
Get alerts when Laboratoires Thea's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free